171 related articles for article (PubMed ID: 38457125)
1. Biologic Therapy in Rare Eosinophil-Associated Disorders: Remaining Questions and Translational Research Opportunities.
Khoury P; Roufosse F; Kuang FL; Ackerman SJ; Akuthota P; Bochner BS; Johansson MW; Mathur SK; Ogbogu PU; Spencer LA; Wechsler ME; Zimmermann N; Klion AD;
J Leukoc Biol; 2024 Mar; ():. PubMed ID: 38457125
[TBL] [Abstract][Full Text] [Related]
2. Eosinophil-associated diseases: the allergist's and clinical immunologist's perspective.
Marra AM; Rossi CM; Piga MA; Moroncini G; Bilò MB
Eur Ann Allergy Clin Immunol; 2024 Mar; ():. PubMed ID: 38546414
[TBL] [Abstract][Full Text] [Related]
3. Improving Care in Eosinophil-Associated Diseases: A Charter.
Jackson DJ; Akuthota P; Andradas R; Bredenoord AJ; Cordell A; Gray S; Kullman J; Mathur SK; Pavord I; Roufosse F; Rubio C; Rusek IC; Simon D; Strobel MJ; Winders T
Adv Ther; 2022 Jun; 39(6):2323-2341. PubMed ID: 35489014
[TBL] [Abstract][Full Text] [Related]
4. Revisiting the NIH Taskforce on the Research needs of Eosinophil-Associated Diseases (RE-TREAD).
Khoury P; Akuthota P; Ackerman SJ; Arron JR; Bochner BS; Collins MH; Kahn JE; Fulkerson PC; Gleich GJ; Gopal-Srivastava R; Jacobsen EA; Leiferman KM; Francesca LS; Mathur SK; Minnicozzi M; Prussin C; Rothenberg ME; Roufosse F; Sable K; Simon D; Simon HU; Spencer LA; Steinfeld J; Wardlaw AJ; Wechsler ME; Weller PF; Klion AD
J Leukoc Biol; 2018 Jul; 104(1):69-83. PubMed ID: 29672914
[TBL] [Abstract][Full Text] [Related]
5. Cardiopulmonary and Gastrointestinal Manifestations of Eosinophil- associated Diseases and Idiopathic Hypereosinophilic Syndromes: Multimodality Imaging Approach.
Katre RS; Sunnapwar A; Restrepo CS; Katabathina VS; Mumbower A; Baxi A; Sonavane S
Radiographics; 2016; 36(2):433-51. PubMed ID: 26963455
[TBL] [Abstract][Full Text] [Related]
6. Current and emerging biologic therapies targeting eosinophilic disorders.
Pitlick MM; Li JT; Pongdee T
World Allergy Organ J; 2022 Aug; 15(8):100676. PubMed ID: 35983569
[TBL] [Abstract][Full Text] [Related]
7. Unmet needs and evidence gaps in hypereosinophilic syndrome and eosinophilic granulomatosis with polyangiitis.
Wechsler ME; Hellmich B; Cid MC; Jayne D; Tian X; Baylis L; Roufosse F
J Allergy Clin Immunol; 2023 Jun; 151(6):1415-1428. PubMed ID: 37086239
[TBL] [Abstract][Full Text] [Related]
8. Real-World Investigation of Eosinophilic-Associated Disease Overlap (REVEAL): Analysis of a US Claims Database.
Brailean A; Kwiatek J; Kielar D; Katial R; Wang X; Xu X; Kim YJ; Stokes M; Stirnadel-Farrant HA
Allergy Asthma Immunol Res; 2023 Sep; 15(5):580-602. PubMed ID: 37827978
[TBL] [Abstract][Full Text] [Related]
9. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.
Wechsler ME; Klion AD; Paggiaro P; Nair P; Staumont-Salle D; Radwan A; Johnson RR; Kapoor U; Khokhar FA; Daizadeh N; Chen Z; Laws E; Ortiz B; Jacob-Nara JA; Mannent LP; Rowe PJ; Deniz Y
J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2695-2709. PubMed ID: 35636689
[TBL] [Abstract][Full Text] [Related]
10. An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic Syndromes.
Chen MM; Roufosse F; Wang SA; Verstovsek S; Durrani SR; Rothenberg ME; Pongdee T; Butterfield J; Lax T; Wechsler ME; Stein ML; Ogbogu PU; Kahwash BM; Mathur SK; Simon D; Akuthota P; Holland N; Wetzler L; Ware JM; Guo C; Fay MP; Khoury P; Klion AD; Bochner BS
J Allergy Clin Immunol Pract; 2022 May; 10(5):1217-1228.e3. PubMed ID: 35181548
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Biological Markers in Hypereosinophilic Syndromes.
Khoury P; Makiya M; Klion AD
Front Med (Lausanne); 2017; 4():240. PubMed ID: 29312946
[TBL] [Abstract][Full Text] [Related]
12. Mepolizumab: 240563, anti-IL-5 monoclonal antibody - GlaxoSmithKline, anti-interleukin-5 monoclonal antibody - GlaxoSmithKline, SB 240563.
Drugs R D; 2008; 9(2):125-30. PubMed ID: 18298130
[TBL] [Abstract][Full Text] [Related]
13. Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease.
Kuang FL; De Melo MS; Makiya M; Kumar S; Brown T; Wetzler L; Ware JM; Khoury P; Collins MH; Quezado M; Pittaluga S; Klion AD
J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1598-1605.e2. PubMed ID: 35283330
[TBL] [Abstract][Full Text] [Related]
14. Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report.
Klion AD; Bochner BS; Gleich GJ; Nutman TB; Rothenberg ME; Simon HU; Wechsler ME; Weller PF;
J Allergy Clin Immunol; 2006 Jun; 117(6):1292-302. PubMed ID: 16750989
[TBL] [Abstract][Full Text] [Related]
15. Acute exacerbation of idiopathic hypereosinophilic syndrome following asymptomatic coronavirus disease 2019: a case report.
Suzuki S; Suzuki K; Ichikawa T; Takahashi K; Minami-Hori M; Tanino Y
J Med Case Rep; 2022 Aug; 16(1):324. PubMed ID: 36042524
[TBL] [Abstract][Full Text] [Related]
16. Biological Modulators in Eosinophilic Diseases.
Sriaroon P; Ballow M
Clin Rev Allergy Immunol; 2016 Apr; 50(2):252-72. PubMed ID: 25129490
[TBL] [Abstract][Full Text] [Related]
17. Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis.
Grayson PC; Monach PA; Pagnoux C; Cuthbertson D; Carette S; Hoffman GS; Khalidi NA; Koening CL; Langford CA; Maksimowicz-McKinnon K; Seo P; Specks U; Ytterberg SR; Merkel PA;
Rheumatology (Oxford); 2015 Aug; 54(8):1351-9. PubMed ID: 25406357
[TBL] [Abstract][Full Text] [Related]
18. Biologics for the Treatment of Allergic Conditions: Eosinophil Disorders.
Olivieri B; Tinazzi E; Caminati M; Lunardi C
Immunol Allergy Clin North Am; 2020 Nov; 40(4):649-665. PubMed ID: 33012326
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal Manifestations of Hypereosinophilic Syndromes and Mast Cell Disorders: a Comprehensive Review.
Nanagas VC; Kovalszki A
Clin Rev Allergy Immunol; 2019 Oct; 57(2):194-212. PubMed ID: 30003499
[TBL] [Abstract][Full Text] [Related]
20. Plain Language Summary of principles for improving the care of people with eosinophil-associated diseases.
J Jackson D; Akuthota P; Andradas R; J Bredenoord A; Cordell A; Gray S; Kullman J; Mathur SK; Pavord I; Roufosse F; Rubio C; Rusek IC; Simon D; Strobel MJ; Winders T
Immunotherapy; 2023 May; ():. PubMed ID: 37194573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
